Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical program. [electronic resource]
Producer: 20000802Description: 57-62 p. digitalISSN:- 0732-8893
- Anti-Bacterial Agents -- therapeutic use
- Community-Acquired Infections -- complications
- Drug Resistance, Microbial
- Drug Therapy, Combination -- therapeutic use
- Enterococcus faecium -- drug effects
- Global Health
- Humans
- International Cooperation
- Pneumonia, Bacterial -- complications
- Pneumonia, Staphylococcal -- complications
- Skin Diseases, Bacterial -- complications
- Staphylococcal Skin Infections -- complications
- Staphylococcus aureus -- drug effects
- Virginiamycin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.